Sonoma Pharmaceuticals, Inc. (SNOA) vs China SXT Pharmaceuticals, Inc. (SXTC)
Sonoma Pharmaceuticals, Inc. and China SXT Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Sonoma Pharmaceuticals, Inc. is the larger, with a market value of $6.0M against $3.5M — 1.7× the size. Sonoma Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 47.0% against −54.0%. Sonoma Pharmaceuticals, Inc. has the higher net margin (−10.3% vs −255.2%) and the lower return on invested capital (−70.0% vs 0.00%). Across the 17 metrics below, China SXT Pharmaceuticals, Inc. leads on 9 and Sonoma Pharmaceuticals, Inc. on 8.
Valuation
Profitability
| Metric | SNOA | SXTC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 38.91% | 36.69% | 53.94% |
| Operating margin | (6.41%) | 0.00% | 0.00% |
| Net margin | (10.33%) | (255.16%) | 0.00% |
| Free cash flow margin | (12.11%) | 0.00% | 0.00% |
| Return on equity | (42.52%) | 0.00% | (0.40%) |
| Return on assets | (13.85%) | 0.00% | (3.32%) |
| Return on invested capital | (69.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack